Loading...

Reforms And Rising Costs Will Erode Medicare Margins

Published
14 Apr 25
AnalystLowTarget's Fair Value
US$224.00
16.1% overvalued intrinsic discount
16 Jul
US$260.17
Loading
1Y
-6.9%
7D
0.7%

Author's Valuation

US$22416.1% overvalued intrinsic discount

AnalystLowTarget Fair Value